• Please log in or register to access this feature.

Early Detection and Diagnosis

You have full text access to this OnlineOpen article

Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme

  1. Lieke Hol1,†,*,
  2. Ernst J. Kuipers1,2,
  3. Marjolein van Ballegooijen3,
  4. Anneke J. van Vuuren1,
  5. Jaqueline C.I.Y. Reijerink4,
  6. Dik J.F. Habbema3,
  7. Monique E. van Leerdam1

Article first published online: 16 AUG 2011

DOI: 10.1002/ijc.26260

Issue

International Journal of Cancer

International Journal of Cancer

Volume 130, Issue 9, pages 2096–2102, 1 May 2012

Additional Information

How to Cite

Hol, L., Kuipers, E. J., van Ballegooijen, M., van Vuuren, A. J., Reijerink, J. C.I.Y., Habbema, D. J.F. and van Leerdam, M. E. (2012), Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme. Int. J. Cancer, 130: 2096–2102. doi: 10.1002/ijc.26260

Author Information

  1. 1

    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands

  2. 2

    Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands

  3. 3

    Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands

  4. 4

    Cancer Screening Organisation for Southwest Netherlands, Vlaardingen, The Netherlands

  1. †

    Tel: +31-10-7032983, Fax: +31-10-7034682

*Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands

  1. †

    Tel: +31-10-7032983, Fax: +31-10-7034682

Publication History

  1. Issue published online: 22 FEB 2012
  2. Article first published online: 16 AUG 2011
  3. Accepted manuscript online: 23 JUN 2011 08:51AM EST
  4. Manuscript Accepted: 10 JAN 2011
  5. Manuscript Received: 22 FEB 2010

Funded by

  • Dutch Cancer Society. Grant Number: EMCR 2006-3673
  • Dutch Ministry of Health, Health Care Prevention Program–Implementation. Grant Number: ZonMw 2006-5877
  • Olympus Medical Systems Europe GmbH, Hamburg, Germany, Eiken Chemical Co., Tokyo, Japan

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (899K)

References

  • 1
    Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 1541–9.
    Direct Link:
  • 2
    Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977–81.
  • 3
    Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653–7.
  • 4
    Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572–5.
  • 5
    Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009; 338: b1846.
  • 6
    Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, Matsuda T, Wu KC, et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008; 57: 1166–76.
  • 7
    Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58: 130–60.
    Direct Link:
  • 8
    Commission of the European Communities Brussels. Council Recommendation on Cancer Screening, 2003/0093. 2003.
  • 9
    Lansdorp-Vogelaar I, van BM, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst 2009; 101: 1412–22.
  • 10
    Loeve F, Brown ML, Boer R, van BM, van Oortmarssen GJ, Habbema JD. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 2000; 92: 557–63.
  • 11
    Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case–control study of 32,702 veterans. Ann Intern Med 1995; 123: 904–10.
  • 12
    Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624–33.
  • 13
    Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, et al. Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”—SCORE. J Natl Cancer Inst 2002; 94: 1763–72.
  • 14
    Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years. Scand J Gastroenterol 2003; 38: 635–42.
  • 15
    Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62–8.
  • 16
    Zorzi M, Fedato C, Naldoni C, Sassatelli R, Sassoli De' BP, Senore C, Visioli CB, Cogo C. Screening for colorectal cancer in Italy: 2007 survey. Epidemiol Prev 2009; 33: 57–74.
  • 17
    Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005; 97: 347–57.
  • 18
    Frew EJ, Wolstenholme JL, Whynes DK. Eliciting relative preferences for two methods of colorectal cancer screening. Eur J Cancer Care (Engl) 2005; 14: 124–31.
    Direct Link:
  • 19
    DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 2008; 23: 169–74.
  • 20
    Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med 1999; 14: 432–7.
    Direct Link:
  • 21
    Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health 2006; 96: 809–11.
  • 22
    Giorgi RP, Federici A, Bartolozzi F, Farchi S, Borgia P, Guasticchi G. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]. BMC Public Health 2005; 5: 139.
  • 23
    Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 2006; 184: 546–50.
  • 24
    Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, Munoz R, Lau C, Somsouk M, El Nachef N, Hayward RA. 124 method of recommendation for colorectal cancer screening strategies impacts adherence. Gastroenterology 2010; 138: S-23.
  • 25
    Marbet UA, Bauerfeind P, Brunner J, Dorta G, Valloton JJ, Delco F. Colonoscopy is the preferred colorectal cancer screening method in a population-based program. Endoscopy 2008; 40: 650–5.
  • 26
    Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, Castiglione G, Grazzini G, Taddei S, Gasperoni S, Giuliani O, Malfitana G, et al. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation. Am J Gastroenterol 2010; 105: 188–198.
  • 27
    Atkin WS, Cook CF, Cuzick J, Edwards R, Northover JM, Wardle J; UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291–300.
  • 28
    Hol L, Wilschut JA, van BM, van Vuuren AJ, van D, V, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009; 100: 1103–10.
  • 29
    van Rossum LG, Van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, Verbeek AL, Dekker E. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009; 101: 1274–81.
  • 30
    Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Rubenstein LZ, Shekelle PG. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136: 641–51.
  • 31
    Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening among adults aged 50–75 years—United States, 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 808–12.
View Full Article (HTML) Get PDF (899K)